The developing brain is susceptible to the neurotoxic effects of lead. Exposure to lead has main effects on the cholinergic system and causes reduction of cholinergic neuron function during brain development. Disruption of the cholinergic system by chemicals, which play important roles during brain development, causes of neurodevelopmental toxicity. Differentiation of stem cells to neural cells is recently considered a promising tool for neurodevelopmental toxicity studies. This study evaluated the toxicity of lead acetate exposure during the differentiation of bone marrow–derived mesenchyme stem cells (bone marrow stem cells, BMSCs) to CCholinergic neurons. Following institutional animal care review board approval, BMSCs were obtained from adult rats. The differentiating protocol included two stages that were pre-induction with β-mercaptoethanol (BME) for 24 h and differentiation to cholinergic neurons with nerve growth factor (NGF) over 5 days. The cells were exposed to different lead acetate concentrations (0.1–100 μm) during three stages, including undifferentiated, pre-induction, and neuronal differentiation stages; cell viability was measured by MTT assay. Lead exposure (0.01–100 μg/ml) had no cytotoxic effect on BMSCs but could significantly reduce cell viability at 50 and 100 μm concentrations during pre-induction and neuronal differentiation stages. MAP2 and choline acetyltransferase (ChAT) protein expression were investigated by immunocytochemistry. Although cells treated with 100 μm lead concentration expressed MAP2 protein in the differentiation stages, they had no neuronal cell morphology. The ChAT expression was negative in cells treated with lead. The present study showed that differentiated neuronal BMSCs are sensitive to lead toxicity during differentiation, and it is suggested that these cells be used to study neurodevelopmental toxicity.
Alinejad-MofradEMalaekeh-NikoueiBGholamiL, et al. (2019) Evaluation and comparison of cytotoxicity, genotoxicity, and apoptotic effects of poly-l-lysine/plasmid DNA micro-and nanoparticles. Human & Experimental Toxicology38(8): 983–991.
2.
ArealLBBlakelyRD (2020) Neurobehavioral changes arising from early life dopamine signaling perturbations. Neurochemistry International137: 104747.
3.
ArnoldLDaganAGutheilJ, et al. (1979) Antineoplastic activity of poly (L-lysine) with some ascites tumor cells. Proceedings of the National Academy of Sciences76(7): 3246–3250.
4.
BarryFPMurphyJM (2004) Mesenchymal stem cells: clinical applications and biological characterization. The International Journal of Biochemistry & Cell Biology36(4): 568–584.
5.
BottenNHodgesRRLiD, et al. (2019) Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells. The FASEB Journal33(7): 8468–8478.
6.
Bui ThiNHNguyen ThiNAAudiraG, et al. (2020) Chronic exposure to low concentration lead chloride-induced anxiety and loss of aggression and memory in zebrafish. International Journal of Molecular Sciences21(5): 1844.
7.
ChenLLiuYJiaP, et al. (2022) Acute lead acetate induces neurotoxicity through decreased synaptic plasticity-related protein expression and disordered dendritic formation in nerve cells. Environmental Science and Pollution Research: 1–9. Online ahead of print.
8.
ChenZHuoXChenG, et al. (2021) Lead (Pb) exposure and heart failure risk. Environmental Science and Pollution Research28(23): 28833–28847.
9.
DavilaJCCezarGGThiedeM, et al. (2004) Use and application of stem cells in toxicology. Toxicological Sciences79(2): 214–223.
10.
DawsonDAHallenbeckJM (1996) Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. Journal of Cerebral Blood Flow & Metabolism16(1): 170–174.
11.
El-MagdMKahiloKNasrN, et al. (2017) A potential mechanism associated with lead-induced testicular toxicity in rats. Andrologia49(9): e12750.
12.
FangYLuLLiangY, et al. (2021) Signal transduction associated with lead-induced neurological disorders: a review. Food and Chemical Toxicology150: 112063.
13.
FloraGGuptaDTiwariA (2012) Toxicity of lead: a review with recent updates. Interdisciplinary Toxicology5(2): 47–58.
14.
GeYChenLSunX, et al. (2018) Lead-induced changes of cytoskeletal protein is involved in the pathological basis in mice brain. Environmental Science and Pollution Research25(12): 11746–11753.
15.
HarrillJAFreudenrichTMRobinetteBL, et al. (2011) Comparative sensitivity of human and rat neural cultures to chemical-induced inhibition of neurite outgrowth. Toxicology and Applied Pharmacology256(3): 268–280.
16.
HarryGJBillingsleyMBruininkA, et al. (1998) In vitro techniques for the assessment of neurotoxicity. Environmental Health Perspectives106(suppl 1): 131–158.
17.
HouslayMDKolchW (2000) Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Molecular Pharmacology58(4): 659–668.
18.
HuangFSchneiderJ (2004) Effects of lead exposure on proliferation and differentiation of neural stem cells derived from different regions of embryonic rat brain. Neurotoxicology25(6): 1001–1012.
19.
KargaranPKMosqueiraDKoziczT (2021) Mitochondrial medicine: genetic underpinnings and disease modeling using induced pluripotent stem cell technology. Frontiers in Cardiovascular Medicine7: 416.
20.
KellerG (2005) Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes & Development19(10): 1129–1155.
KhawajaAMRogersDF (1996) Tachykinins: receptor to effector. The International Journal of Biochemistry & Cell Biology28(7): 721–738.
23.
LanghansSA (2018) Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Frontiers in Pharmacology9: 6.
24.
Le LargeTYSEl HassouniBFunelN, et al. (2019) Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment. Therapeutic Advances in Medical Oncology11: 1758835919841233.
25.
LéránthCFrotscherM (1987) Cholinergic innervation of hippocampal GAD and somatostatin-immunoreactive commissural neurons. Journal of Comparative Neurology261(1): 33–47.
26.
LiYBaMDuY, et al. (2019) Aβ1-42 increases the expression of neural KATP subunits Kir6. 2/SUR1 via the NF-κB, p38 MAPK and PKC signal pathways in rat primary cholinergic neurons. Human & Experimental Toxicology38(6): 665–674.
27.
MasonLHHarpJPHanDY (2014) Pb neurotoxicity: neuropsychological effects of lead toxicity. BioMed research international2014: 840547.
28.
MenonAVChangJKimJ (2016) Mechanisms of divalent metal toxicity in affective disorders. Toxicology339: 58–72.
29.
NaghdiMALTARIHITMESBAHNS, et al. (2009a) Induction of bone marrow stromal cells into cholinergic-like cells by nerve growth factor. Iranian Biomedical Journal13(2): 117–123.
30.
NaghdiMNaghdiMTiraihiT, et al. (2009b) Transdifferentiation of bone marrow stromal cells into cholinergic neuronal phenotype: a potential source for cell therapy in spinal cord injury. Cytotherapy11(2): 137–152.
31.
PelazBAlexiouCAlvarez-PueblaRA, et al. (2017) Diverse applications of nanomedicine. ACS Nano11(3): 2313–2381.
32.
Qasemian LemraskiMSoodiMFakhr TahaM, et al. (2015) Study of lead-induced neurotoxicity in neural cells differentiated from adipose tissue-derived stem cells. Toxicology Mechanisms and Methods25(2): 128–135.
33.
RadioNMMundyWR (2008) Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology29(3): 361–376.
34.
RissTLMoravecRANilesAL, et al. (2016) Cell viability assays. In: MarkossianSGrossmanABrimacombeK, et al. (eds) Assay Guidance Manual. Bethesda, MD: Eli Lilly & Company and the National Center for Advancing Translational Sciences.
35.
Sanchez-RamosJSongSCardozo-PelaezF, et al. (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Experimental Neurology164(2): 247–256.
36.
ShibueTWeinbergRA (2017) EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nature Reviews Clinical Oncology14(10): 611–629.
37.
ShuaiK (2000) Modulation of STAT signaling by STAT-interacting proteins. Oncogene19(21): 2638–2644.
38.
SlivickiRAAliYOLuH-C, et al. (2016) Impact of genetic reduction of NMNAT2 on chemotherapy-induced losses in cell viability in vitro and peripheral neuropathy in vivo. PLoS ONE11(1): e0147620.
39.
SunCShaoJSuL, et al. (2013) Cholinergic neuron-like cells derived from bone marrow stromal cells induced by tricyclodecane-9-yl-xanthogenate promote functional recovery and neural protection after spinal cord injury. Cell Transplantation22(6): 961–975.
40.
UllahISubbaraoRBRhoGJ (2015) Human mesenchymal stem cells-current trends and future prospective. Bioscience Reports35(2): e00191.
41.
VerstraetenSVAimoLOteizaPI (2008) Aluminium and lead: molecular mechanisms of brain toxicity. Archives of Toxicology82(11): 789–802.
42.
VillaCSuphesizHCombiR, et al. (2020) Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer’s disease: an update. Mechanisms of Ageing and Development185: 111197.
WrightJPLanphearBPDietrichKN, et al. (2021) Developmental lead exposure and adult criminal behavior: a 30-year prospective birth cohort study. Neurotoxicology and Teratology85: 106960.
45.
ZareiMHSoodiMQasemian-LemraskiM, et al. (2016) Study of the chlorpyrifos neurotoxicity using neural differentiation of adipose tissue-derived stem cells. Environmental Toxicology31(11): 1510–1519.
46.
ZhangXWengMChenZ (2021) Fibroblast Growth Factor 9 (FGF9) negatively regulates the early stage of chondrogenic differentiation. PLoS ONE16(2): e0241281.
